According to reports, PHD1 is activated in colon biopsies from patients with IBD, and its elevated levels are correlated with apoptosis in IBD, especially in UC, as well as with pro-inflammatory markers such as IL-8 and TNF-α [114]. Here, EGLN2 is linked to inflammatory bowel disease.